Suche Forschungsprojekt
Weitere Suchoptionen
40 Ergebnis(se)
Abgeschlossene Forschungsprojekte = 
Förderung durch ein IRDiRC-Mitglied = 
Studie unter Beteiligung von ERN-Mitgliedern aus mindestens zwei Mitgliedstaaten = 
Forschungsprojekt(e)
OSTERREICH
TIROL
INNSBRUCK
TECANT: Novel 99mTc-labeled somatostatin receptor antagonists in the diagnostic algorithm of neuroendocrine neoplasms - a feasibility study - AT
Medizinische Universität Innsbruck
Universitätsklinik für Nuklearmedizin
OSTERREICH
TIROL
INNSBRUCK
Prospective study of 68GA-NODAGA-RGD-PET for the non-invasive determination of the Integrin avb3 expression in patients with untreated or recurrent breast cancer, colorectal cancer, non-small cell lung cancer or neuroendocrine tumors - AT
Medizinische Universität Innsbruck
Universitätsklinik für Nuklearmedizin
PORTUGAL
NORTE
PORTO
Unraveling the genetics of neuroendocrine tumors by high throughput methods
Instituto de Patologia e Imunologia Molecular da Universidade do Porto
Grupo de Oncobiologia
PORTUGAL
NORTE
PORTO
Sorting out the genetics of neuroendocrine tumours
Instituto de Patologia e Imunologia Molecular da Universidade do Porto
Grupo de Oncobiologia
BELGIEN
ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - BE
BELGIEN
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - BE
EORTC
European Organisation for the Research and Treatment of Cancer
BELGIEN
ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS
Follow-up of Fertility in Young Adults Who Did or Did Not Store Testicular Tissue Before Gonadotoxic Treatment for Fertility Preservation
Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel)
DEUTSCHLAND
Baden-Württemberg
FREIBURG
MTB-FR: Registerstudie des Molekularen Tumorboards (Tumorentitäten-übergreifendes molekulares Charakterisierungsprogramm zur Evaluierung individualisierter, Tumorbiologie geleiteter Therapie bei Erwachsenen mit seltenen und fortgeschrittenen Tumorentitäten
Universitätsklinikum Freiburg
Klinik für Innere Medizin I - Hämatologie, Onkologie und Stammzelltransplantation
DEUTSCHLAND
Baden-Württemberg
HEIDELBERG
ERA-NET TRANSCAN: BRCAddict - BRCAness als therapeutisches Ziel bei kindlichen soliden Hochrisiko-Tumoren
Deutsches Krebsforschungszentrum
KITZ - Hopp-Kindertumorzentrum Heidelberg
DEUTSCHLAND
Bayern
AUGSBURG
CancerEvo: Untersuchung der Evolution in sporadischen und Tumordispositionssyndrom-assoziierten Tumoren
Universitätsklinikum Augsburg
II. Medizinische Klinik
DEUTSCHLAND
Berlin
ADDRESS: NOT PROVIDED - DE
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - DE
Institution: Information not provided - DE
DEUTSCHLAND
Berlin
ADDRESS: NOT PROVIDED - DE
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - DE
ISRAEL
ISRAEL
ADDRESS: NOT PROVIDED - IL
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - IL
Institution: Information not provided - IL
ISRAEL
ISRAEL
ADDRESS: NOT PROVIDED - IL
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - IL
ITALIEN
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - IT
Institution: Information not provided - IT
ITALIEN
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - IT
ITALIEN
VENETO
PADOVA
Modulating BMP axis to prevent muscle loss, dismantling of NMJ and denervation in cancer cachexia
Venetian Institute of Molecular Medicine
Fondazione per la ricerca Biomedica avanzata ONLUS
KANADA
Ontario
TORONTO
Beyond the Genome: Transcriptome Based Diagnostics for Rare Diseases and Cancer
Hospital for Sick Children, Research Institute
NIEDERLANDE
Utrecht
ADDRESS: NOT PROVIDED - NL
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - NL
Institution: Information not provided - NL
NIEDERLANDE
Utrecht
ADDRESS: NOT PROVIDED - NL
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - NL
OSTERREICH
WIEN
ADDRESS: NOT PROVIDED - AT
A Quality Improvement Project to Implement Psychosocial Care Standards in Clinical Practice in Pediatric Oncology "My Logbook! - I Know my Way Around!" Development and Evaluation of a Consensus and Evidence Based Psychosocial Therapy Tool in a Preliminary Psychosocial Study on Therapy Optimization - AT
Institution: Information not provided - AT
OSTERREICH
WIEN
WIEN
PanCareSurPass: PanCare studies of the scale-up and implementation of the digital Survivorship Passport to improve people-centred care for childhood cancer survivors - AT
Gesundheit Österreich GmbH
OSTERREICH
WIEN
WIEN
Christian Doppler-Labor für CAR-T-Zellen der nächsten Generation
St. Anna Kinderkrebsforschung
Children's Cancer Research Institute
OSTERREICH
WIEN
WIEN
Instand-NGS4P: Integrated and standardized NGS workflows for Personalised therapy - AT
St. Anna Kinderkrebsforschung
PORTUGAL
CENTRO
ADDRESS: NOT PROVIDED - PT
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - PT
Institution: Information not provided - PT
PORTUGAL
CENTRO
ADDRESS: NOT PROVIDED - PT
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - PT
TURKEI
TURKEY
ADDRESS: NOT PROVIDED - TR
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - TR
Institution: Information not provided - TR
TURKEI
TURKEY
ADDRESS: NOT PROVIDED - TR
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - TR
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Evaluating utility and improving implementation of genomic sequencing for pediatric cancer patients in the diverse population and healthcare settings of Texas: the kidscanseq study
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Personalized whole body staging for children with cancer: a solution to the conundrum of long-term side effects from ct and pet/ct scans
Institution: Information not provided - US
VEREINIGTE STAATEN
Washington
ADDRESS: NOT PROVIDED - US
Project 1: optimization of therapeutic approaches for children with relapsed sarcomas using precision medicine.
Institution: Information not provided - US
VEREINIGTES KONIGREICH
Greater Manchester
ADDRESS: NOT PROVIDED - UK
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I - GB
Institution: Information not provided - UK
SPANIEN
Andalucía
SEVILLA
Mechanistic models using Machine Learning for therapeutic targets discovery and drug repurposing in Rare Diseases
Fundación Progreso y Salud
Área de bioinformática clínica
Multizentrische Forschungsprojekte
- Institution: Information not provided - DE
- Tata Memorial Centre
- Advanced Centre for Treatment, Research and Education in Cancer
- Institution: Information not provided - IT
- Fondazione IRCCS Istituto Nazionale dei Tumori
- S.S. di Epidemiologia Valutativa
- St. Anna Kinderkrebsforschung
- Children's Cancer Research Institute
- Northern Institute for Cancer Research, Medical School, Newcastle University
- Northern Institute for Cancer Research
- Institut Curie
- Macromolécules et Microsystèmes en Biologie et en Medecine
DEUTSCHLAND
Berlin
ADDRESS: NOT PROVIDED - DE
TORPEDO: Zielgerichtete Bekämpfung von Resistenzen in der pädiatrischen Onkologie
INDIEN
INDIA
MAHARASHTRA
Development of a Module to Assess the Patients Financial Burden Related to Cancer Treatment-Financial Toxicity-Phase I
ITALIEN
EMILIA ROMAGNA
ADDRESS: NOT PROVIDED - IT
TRANSCAN-2: Aligning national/regional translational cancer research programmes and activities
ITALIEN
LOMBARDIA
MILANO
RARECARE: surveillance of rare cancers in Europe
OSTERREICH
WIEN
WIEN
ExPO-r-Net: European Expert Paediatric Oncology Reference Network for Diagnostics and Treatment
VEREINIGTES KONIGREICH
Tyne & Wear
NEWCASTLE UPON TYNE
EPOC: European paediatric oncology off-patent medicines consortium
FRANKREICH
ILE-DE-FRANCE
ORSAY